Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 [SEBI (LODR) Regulations, 2015], we wish to inform you that the Board of Directors ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rajkamal Synthetics' board, at its meeting on February 2, 2026, approved the unaudited standalone and consolidated financial results for Q3 FY26 and the nine months ended December 31, 2025, along with the limited review report from ADV & Associates. On a standalone basis, revenue from operations for Q3 FY26 was around ₹133 lakh with a net profit of about ₹5 lakh, while 9M FY26 revenue came in at roughly ₹493 lakh versus ₹207 lakh in 9M FY25, and net profit for 9M FY26 stood at ₹8.57 lakh versus ₹5.46 lakh earlier, indicating strong top-line and earnings growth. On a consolidated basis, 9M FY26 revenue surged to about ₹596 lakh from ₹83 lakh a year ago, helped by the consolidation of newly acquired entities. A key highlight is the company's strategic expansion: it acquired 100% stakes in Eliraluxe Skincare Pvt Ltd and RKR Mines & Minerals Pvt Ltd, and a 51% stake in Indoframe Industries Pvt Ltd during the quarter, with Indoframe now a partially-owned subsidiary. The auditor flagged these acquisitions as an 'Emphasis of Matter' in the review report, while confirming no modifications to the review opinion.
The sharp revenue jump reflects a real transformation through acquisitions rather than purely organic growth, so investors should look at standalone numbers to gauge the core business trajectory. The Q3 standalone PAT remains small, but the build-out of a subsidiary structure could be a positive long-term signal for a micro-cap company (paid-up capital of about ₹6.5 crore). Watch for further updates on how the new subsidiaries contribute to margins and whether the consolidated earnings sustain post the initial consolidation boost.